Impact Biomedical (IBO) Notes Payables (2022 - 2025)
Impact Biomedical's (IBO) quarterly Notes Payables came in at $22.9 million in Q3 2025, up 65274.29% YoY from N/an in Q3 2024, and up 2.37% on a QoQ basis from $22.4 million in Q2 2025.
Impact Biomedical (IBO) Notes Payables (2022 - 2025) Analysis & Trends
Impact Biomedical (IBO) has 4 years of Notes Payables data on file, last reported at $22.9 million in Q3 2025.
- Quarterly Notes Payables rose 65274.29% year-over-year to $22.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $22.9 million (up 65274.29% YoY) and the FY2024 annual result came in at $8.9 million, down 26.47% from the prior year.
- Notes Payables improved to $22.9 million in Q3 2025, from $22.4 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $22.9 million in Q3 2025 to a low of $35000.0 in Q3 2024.
- A 4-year average of $12.3 million and a median of $11.8 million in 2023 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables tumbled 99.7% — and 2025, when it surged 65274.29%.
- Tracing IBO's Notes Payables over 4 years: stood at $10.0 million in 2022, then increased by 20.85% to $12.1 million in 2023, then fell by 26.47% to $8.9 million in 2024, then soared by 157.73% to $22.9 million in 2025.
- The last three Notes Payables figures came in at $22.9 million (Q3 2025), $22.4 million (Q2 2025), and $9.1 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Impact Biomedical | 49.54 Mn | 49.53 Mn | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 22.88 Mn |
| Jun 30, 2025 | 22.35 Mn |
| Mar 31, 2025 | 9.14 Mn |
| Dec 31, 2024 | 8.88 Mn |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 13.45 Mn |
| Mar 31, 2024 | 12.79 Mn |
| Dec 31, 2023 | 12.07 Mn |
| Sep 30, 2023 | 11.78 Mn |
| Jun 30, 2023 | 11.75 Mn |
| Dec 31, 2022 | 9.99 Mn |